Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Sexual Dysfunctions, Psychological: later-stage trial registry
1 of 3 indexed Sexual Dysfunctions, Psychological trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Sexual Dysfunctions, Psychological: 3 US clinical trials tracked, 1 recruiting.
Sexual Dysfunctions, Psychological is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Sprout Pharmaceuticals, running 2 of these trials.
Enrollment posture brief
Registry condition sexual-dysfunctions-psychological
OPEN 1 | RECR 33% | LATE 3 | EARLY 0 | RANK #5209 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Sexual Dysfunctions, Psychological lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Sexual Dysfunctions, Psychological on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Sexual Dysfunctions, Psychological is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
University of Miami
NCT05777031
Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
Sprout Pharmaceuticals
NCT00360555
Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
Sprout Pharmaceuticals
NCT00996372
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Sexual Dysfunctions, Psychological records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Sexual Dysfunctions, Psychological trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Sexual Dysfunctions, Psychological page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Sexual Dysfunctions, Psychological trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Sprout Pharmaceuticals sponsors the most Sexual Dysfunctions, Psychological trials on record, review their full trial history before evaluating a specific study. See Sprout Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sexual Dysfunctions, Psychological condition card totals 3 registered trials; most-linked intervention flibanserin; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.